<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599813490896</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599813490896</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>General Otolaryngology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Localized Tongue Amyloidosis</article-title>
<subtitle>A Single Institutional Case Series</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>O’Reilly</surname><given-names>Ashley</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813490896">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>D’Souza</surname><given-names>Anita</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599813490896">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lust</surname><given-names>John</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599813490896">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Price</surname><given-names>Daniel</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599813490896">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599813490896"><label>1</label>Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota, USA</aff>
<aff id="aff2-0194599813490896"><label>2</label>Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA</aff>
<author-notes>
<corresp id="corresp1-0194599813490896">Ashley O’Reilly, MD, Mayo Clinic, Department of Otorhinolaryngology, 200 1st St SW, Rochester, MN 55905, USA. Email: <email>oreilly.ashley@mayo.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>149</volume>
<issue>2</issue>
<fpage>240</fpage>
<lpage>244</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>2</month>
<year>2013</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>4</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>4</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599813490896">
<title>Objective</title>
<p>Review Mayo Clinic experience of localized tongue amyloidosis.</p>
</sec>
<sec id="section2-0194599813490896">
<title>Study Design</title>
<p>Case series with retrospective chart review.</p>
</sec>
<sec id="section3-0194599813490896">
<title>Setting</title>
<p>Academic medical center.</p>
</sec>
<sec id="section4-0194599813490896">
<title>Subjects and Methods</title>
<p>Cases of localized tongue amyloidosis were identified from the dysproteinemia database at the Mayo Clinic in Rochester, Minnesota. Electronic records were reviewed with focus on presenting symptoms, laboratory results (ie, serum or urine immunoelectrophoresis, bone marrow biopsy, and fat aspirate analysis), treatment modality, and status of disease at follow-up.</p>
</sec>
<sec id="section5-0194599813490896">
<title>Results</title>
<p>Six cases of localized tongue amyloidosis presented to the Mayo Clinic between 1969 and 2011. Mean patient age was 69 years (range, 43-90). Patients presented with asymptomatic tongue mass(es). Biopsy of the tongue mass in all patients showed amyloid on Congo red stains. Work-up for systemic amyloidosis, including bone marrow biopsy, fat aspiration, and serum and urine protein immunoelectrophoresis, was negative for all 6 patients, nor was there other organ involvement. Two patients underwent resection of the lesions, and the remaining patients elected for observation. Recurrence requiring repeat excision occurred in 1 of the patients that underwent resection. Repeat evaluation for systemic involvement was performed in 3 patients 1 to 3 years after the initial diagnosis. None of these patients went on to develop systemic involvement.</p>
</sec>
<sec id="section6-0194599813490896">
<title>Conclusions</title>
<p>Localized tongue amyloidosis remains a rare diagnosis and requires exclusion of systemic involvement. Localized lesions may be observed or resected; however, recurrence may occur with resection. Patients with localized tongue amyloidosis do not appear to be at increased risk of developing systemic involvement.</p>
</sec>
</abstract>
<kwd-group>
<kwd>head and neck</kwd>
<kwd>localized amyloidosis</kwd>
<kwd>hematology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section7-0194599813490896" sec-type="intro">
<title>Introduction</title>
<p>Amyloidosis is a disease characterized by extracellular deposits of proteinaceous material in various organs. These deposits are identified by apple-green birefringence when stained with Congo red and viewed under polarized light. Over 25 different proteins have been associated with amyloidosis.<sup><xref ref-type="bibr" rid="bibr1-0194599813490896">1</xref></sup> Amyloid deposits can occur locally in any tissue or may involve several organs, resulting in a wide range of clinical manifestations. There are 4 broad categories of amyloidosis: primary systemic amyloidosis, secondary systemic amyloidosis, hereditary systemic amyloidosis, and localized amyloidosis. Mean survival of patients with the systemic forms is between 5 to 15 months.<sup><xref ref-type="bibr" rid="bibr2-0194599813490896">2</xref></sup> Patients with localized forms, however, have excellent prognosis and are not at increased risk of developing systemic involvement.<sup><xref ref-type="bibr" rid="bibr3-0194599813490896">3</xref></sup> Although localized disease in the head and neck is well reported in the literature, particularly in the larynx, involvement of the tongue is almost always associated with the systemic forms of amyloidosis.<sup><xref ref-type="bibr" rid="bibr4-0194599813490896">4</xref></sup> Amyloidosis localized to the tongue, with no other systemic manifestations, is extremely rare, with only 12 cases reported in the literature.<sup><xref ref-type="bibr" rid="bibr3-0194599813490896">3</xref><xref ref-type="bibr" rid="bibr4-0194599813490896"/><xref ref-type="bibr" rid="bibr5-0194599813490896"/><xref ref-type="bibr" rid="bibr6-0194599813490896"/><xref ref-type="bibr" rid="bibr7-0194599813490896"/><xref ref-type="bibr" rid="bibr8-0194599813490896"/><xref ref-type="bibr" rid="bibr9-0194599813490896"/><xref ref-type="bibr" rid="bibr10-0194599813490896"/>-<xref ref-type="bibr" rid="bibr11-0194599813490896">11</xref></sup> We present 6 cases of localized tongue amyloidosis identified at our institution.</p>
</sec>
<sec id="section8-0194599813490896" sec-type="methods">
<title>Methods</title>
<p>The study was approved by the Mayo Clinic institutional review board. We reviewed a prospectively maintained dysproteinemia database of all patients at Mayo Clinic with biopsy proven amyloidosis. Patients who underwent tongue biopsy were identified. Patients were excluded who did not have isolated tongue amyloidosis.</p>
<p>The diagnosis of amyloidosis was made with Congo red staining. Clinical data including the presenting symptoms, examination findings, results of laboratory and imaging studies, treatment modality, and status of disease at last follow-up were abstracted.</p>
</sec>
<sec id="section9-0194599813490896" sec-type="results">
<title>Results</title>
<p>We identified 140 patients in our database with amyloid and tongue biopsies that were performed between 1969 and 2011. Of these, 6 patients had localized tongue amyloidosis and are the subjects of this article, whereas the rest were secondary macroglossia from systemic amyloidosis. Further amyloid subtyping was performed based on institution practice during the period of identification. Three patients had an amyloid subtype. One patient had amyloid proteomic analysis using tandem mass spectrometry, and 2 patients had immunohistochemistry results.</p>
<p>The mean age at diagnosis in this case series was 69 years (range, 43-90). Five patients presented with an isolated tongue mass, and 1 patient presented with 2 tongue masses as well as a left lateral pharyngeal wall mass. All patients were asymptomatic of their masses and had no other constitutional symptoms (<xref ref-type="fig" rid="fig1-0194599813490896"><bold>Figure 1</bold></xref>). Biopsy of the tongue mass in all patients, and the left lateral pharyngeal wall mass, showed amyloid on Congo red stains. Systemic amyloid evaluation, including bone marrow biopsy, fat aspiration, serum and urine protein immunoelectrophoresis, as well as testing for other organ involvement such as cardiac imaging with echocardiogram and/or MRI and 24-hour urine protein measurement, were negative in all 6 patients. Two patients underwent resection of the mass, and the remaining patients elected for observation. One patient in which the mass was resected developed a recurrence in the lesion within 1 year, requiring repeat excision. Three patients underwent repeat evaluation for systemic involvement 6 months to 2 years after the initial diagnosis and continued to remain free of systemic involvement. The 3 other patients were only seen for an initial consultation and were not followed at our institution. See <xref ref-type="table" rid="table1-0194599813490896"><bold>Table 1</bold></xref> for a summary of information.</p>
<fig id="fig1-0194599813490896" position="float">
<label>Figure 1.</label>
<caption>
<p>Rubbery, well-circumscribed dorsal tongue lesion.</p>
</caption>
<graphic xlink:href="10.1177_0194599813490896-fig1.tif"/>
</fig>
<table-wrap id="table1-0194599813490896" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical data of patients with localized amyloidosis of the tongue.</p>
</caption>
<graphic alternate-form-of="table1-0194599813490896" xlink:href="10.1177_0194599813490896-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Patient</th>
<th align="center">Age</th>
<th align="center">Presenting Symptom</th>
<th align="center">Amyloid Type</th>
<th align="center">Systemic Work-Up<sup><xref ref-type="table-fn" rid="table-fn1-0194599813490896">a</xref></sup></th>
<th align="center">Recommendation</th>
<th align="center">Follow-Up<sup><xref ref-type="table-fn" rid="table-fn2-0194599813490896">b</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td>Patient 1</td>
<td>43-year-old female</td>
<td>1.5-cm rightsided dorsal tongue mass</td>
<td>AL (lambda)</td>
<td>Negative</td>
<td>Resection of mass</td>
<td>None</td>
</tr>
<tr>
<td>Patient 2</td>
<td>72-year-old male</td>
<td>2-cm central dorsal tongue mass</td>
<td>AL (lambda)</td>
<td>Negative</td>
<td>Observation</td>
<td>None</td>
</tr>
<tr>
<td>Patient 3</td>
<td>73-year-old female</td>
<td>Central dorsal tongue mass</td>
<td>AL (lambda)</td>
<td>Negative</td>
<td>Observation</td>
<td>3 years: negative systemic work-up</td>
</tr>
<tr>
<td>Patient 4</td>
<td>74-year-old male</td>
<td>2 1-cm masses on left base of tongue, 2.0-1.5 cm lateral pharyngeal wall mass</td>
<td/>
<td>Negative</td>
<td>Observation</td>
<td>None</td>
</tr>
<tr>
<td>Patient 5</td>
<td>64-year-old male</td>
<td>Central dorsal tongue mass</td>
<td/>
<td>Negative</td>
<td>Observation</td>
<td>2 years: negative systemic work-up</td>
</tr>
<tr>
<td>Patient 6</td>
<td>90-year-old female</td>
<td>Several lesions on tongue base</td>
<td/>
<td>Negative</td>
<td>Resection of lesions</td>
<td>1 year: recurrence of lesions, negative systemic work-up</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599813490896">
<label>a</label>
<p>Systemic work-up at initial diagnosis: bone marrow biopsy, fat aspirate analysis, urine and serum immunoelectrophoresis, cardiac imaging, 24-hour protein.</p>
</fn>
<fn id="table-fn2-0194599813490896">
<label>b</label>
<p>Systemic work-up at follow-up: urine and serum immunoelectrophoresis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section10-0194599813490896" sec-type="discussion">
<title>Discussion</title>
<p>Amyloidosis can be broadly classified as systemic or localized. Historically, systemic amyloidosis is further categorized as primary, secondary, or hereditary. Primary amyloidosis is often associated with lymphoid or plasma call dyscrasias, with or without an overt lymphoma (typically MALT lymphoma, Waldenstrom macroglobinemia) or multiple myeloma. Secondary or reactive amyloidosis is associated with chronic inflammatory systemic disease or chronic dermatosis. The current classification system is now based on the biochemical composition of the amyloid subunit protein.<sup><xref ref-type="bibr" rid="bibr12-0194599813490896">12</xref></sup> Primary amyloidosis is associated with immunoglobulin derived amyloid, usually light chain (AL) type.<sup><xref ref-type="bibr" rid="bibr13-0194599813490896">13</xref></sup> AL amyloidosis has the highest mortality rate and can involve the heart, kidney, nerves, tongue, muscle, gastrointestinal tract, carpal ligaments and skin.<sup><xref ref-type="bibr" rid="bibr14-0194599813490896">14</xref></sup> Head and neck involvement can be seen in both the localized and systemic forms of the disease, with the tongue and larynx as the most frequently affected subsites. The tongue is considered the most common head and neck site of involvement in systemic disease.<sup><xref ref-type="bibr" rid="bibr2-0194599813490896">2</xref>,<xref ref-type="bibr" rid="bibr15-0194599813490896">15</xref></sup></p>
<p>In cases of AL localized amyloidosis, however, the tongue is very rarely involved. The larynx and subglottis are the most commonly encountered head and neck sites in localized amyloidosis.<sup><xref ref-type="bibr" rid="bibr16-0194599813490896">16</xref></sup> Other sites of localized immunoglobulin derived amyloidosis include the tracheobronchial tree,<sup><xref ref-type="bibr" rid="bibr17-0194599813490896">17</xref></sup> bladder,<sup><xref ref-type="bibr" rid="bibr18-0194599813490896">18</xref></sup> lymph nodes, pulmonary parenchyma, skin, and conjunctiva.<sup><xref ref-type="bibr" rid="bibr19-0194599813490896">19</xref></sup></p>
<p>Amyloid involvement of the tongue in systemic amyloidosis most commonly manifests as firm or rubbery macroglossia due to extracellular deposition of amyloid within the suprahyoid muscle. However, localized induration, yellowish nodules, or raised white lesions have also been described in patients with systemic amyloidosis.<sup><xref ref-type="bibr" rid="bibr20-0194599813490896">20</xref></sup> Similarly, localized amyloidosis of the tongue has been described as both isolated nodular lesions as well as diffuse macroglossia.<sup><xref ref-type="bibr" rid="bibr7-0194599813490896">7</xref></sup> Thus, the pattern of tongue involvement is not a reliable finding in differentiating systemic versus localized disease. Thorough systemic evaluation is required to make the distinction.</p>
<p>In cases of progressive macroglossia, surgical reduction can improve complications of deglutition, respiration, cosmetic appearance, and patient comfort.<sup><xref ref-type="bibr" rid="bibr21-0194599813490896">21</xref></sup> In the setting of systemic amyloidosis, the macroglossia is likely to recur if the underlying plasma cell dyscrasia is not medically controlled.<sup><xref ref-type="bibr" rid="bibr22-0194599813490896">22</xref></sup> Although treatment for localized disease is primarily surgical, observation can be undertaken, particularly if the mass is asymptomatic.<sup><xref ref-type="bibr" rid="bibr1-0194599813490896">1</xref></sup> Excision is often curative in cases of localized amyloidosis in the head and neck; however, recurrence can occur.<sup><xref ref-type="bibr" rid="bibr23-0194599813490896">23</xref></sup></p>
<p>Descriptions of localized tongue amyloidosis have been limited to either isolated case reports or included in reviews of localized amyloidosis in the head and neck.<sup><xref ref-type="bibr" rid="bibr3-0194599813490896">3</xref><xref ref-type="bibr" rid="bibr4-0194599813490896"/><xref ref-type="bibr" rid="bibr5-0194599813490896"/><xref ref-type="bibr" rid="bibr6-0194599813490896"/><xref ref-type="bibr" rid="bibr7-0194599813490896"/><xref ref-type="bibr" rid="bibr8-0194599813490896"/><xref ref-type="bibr" rid="bibr9-0194599813490896"/><xref ref-type="bibr" rid="bibr10-0194599813490896"/>-<xref ref-type="bibr" rid="bibr11-0194599813490896">11</xref></sup> In total, 12 cases of localized tongue amyloidosis have been reviewed in the literature. Four of the 12 cases do not document that full systemic evaluation was performed to exclude systemic disease. Seven of the 12 cases do not specify the follow-up for the patients. See <xref ref-type="table" rid="table2-0194599813490896"><bold>Table 2</bold></xref> for details.</p>
<table-wrap id="table2-0194599813490896" position="float">
<label>Table 2.</label>
<caption>
<p>Literature review of localized tongue amyloidosis.</p>
</caption>
<graphic alternate-form-of="table2-0194599813490896" xlink:href="10.1177_0194599813490896-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Authors</th>
<th align="center">Year</th>
<th align="center">Case Series/Case Report</th>
<th align="center">Patient</th>
<th align="center">Tongue Findings</th>
<th align="center">Associated Diseases</th>
<th align="center">Systemic Work-Up</th>
<th align="center">Treatment</th>
<th align="center">Follow-Up</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fahrner et al<sup><xref ref-type="bibr" rid="bibr3-0194599813490896">3</xref></sup></td>
<td>2004</td>
<td>Case report</td>
<td>47-year-old M</td>
<td>Solitary lesion</td>
<td>None</td>
<td>Yes</td>
<td>Resection</td>
<td>9 months. disease free</td>
</tr>
<tr>
<td>Penner et al<sup><xref ref-type="bibr" rid="bibr4-0194599813490896">4</xref></sup></td>
<td>2006</td>
<td>Case series</td>
<td>69-year-old F</td>
<td>Multiple lesions</td>
<td>None</td>
<td>No</td>
<td>Resection</td>
<td>Lost to follow-up</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>46-year-old M</td>
<td>Solitary lesion</td>
<td>None</td>
<td>Yes</td>
<td>Resection</td>
<td>Developed Hodgkins lymphoma 12 years later</td>
</tr>
<tr>
<td>Haraguchi et al<sup><xref ref-type="bibr" rid="bibr5-0194599813490896">5</xref></sup></td>
<td>1997</td>
<td>Case report</td>
<td>62-year-old F</td>
<td>Solitary lesion</td>
<td>Sjogren’s sydrome</td>
<td>Yes</td>
<td>Resection</td>
<td>Recurrence 3 years after resection</td>
</tr>
<tr>
<td>McAlpine and Fuller<sup><xref ref-type="bibr" rid="bibr6-0194599813490896">6</xref></sup></td>
<td>1964</td>
<td>Case series</td>
<td>37-year-old F</td>
<td>Solitary lesion</td>
<td>None</td>
<td>No</td>
<td>Resection</td>
<td>None specified</td>
</tr>
<tr>
<td>Angiero et al<sup><xref ref-type="bibr" rid="bibr7-0194599813490896">7</xref></sup></td>
<td>2010</td>
<td>Case series</td>
<td>36-year-old M</td>
<td>Macroglossia</td>
<td>None</td>
<td>Yes</td>
<td>Biopsy</td>
<td>None specified</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>57-year-old M</td>
<td>Solitary lesion</td>
<td>None</td>
<td>Yes</td>
<td>Biopsy</td>
<td>None specified</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>63-year-old F</td>
<td>Macroglossia</td>
<td>None</td>
<td>No</td>
<td>Biopsy</td>
<td>None specified</td>
</tr>
<tr>
<td>Andreadis et al<sup><xref ref-type="bibr" rid="bibr8-0194599813490896">8</xref></sup></td>
<td>2011</td>
<td>Case report</td>
<td>30-year-old F</td>
<td>Solitary lesion</td>
<td>Neuro-fibromatosis type II</td>
<td>Yes</td>
<td>Resection</td>
<td>6 months, disease free</td>
</tr>
<tr>
<td>Akyildiz et al<sup><xref ref-type="bibr" rid="bibr9-0194599813490896">9</xref></sup></td>
<td>2009</td>
<td>Case report</td>
<td>61-year-old M</td>
<td>Solitary lesion</td>
<td>None</td>
<td>Yes</td>
<td>Resection</td>
<td>4 years, disease free</td>
</tr>
<tr>
<td>Koren et al<sup><xref ref-type="bibr" rid="bibr10-0194599813490896">10</xref></sup></td>
<td>1998</td>
<td>Case report</td>
<td>33-year-old M</td>
<td>Solitary lesion</td>
<td>None</td>
<td>Yes</td>
<td>Resection</td>
<td>None specified</td>
</tr>
<tr>
<td>Yamaoka et al<sup><xref ref-type="bibr" rid="bibr11-0194599813490896">11</xref></sup></td>
<td>1978</td>
<td>Case report</td>
<td>49-year-old F</td>
<td>Solitary lesion</td>
<td>None</td>
<td>No</td>
<td>Resection</td>
<td>None specified</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>We present the first case series in the literature of localized amyloidosis of the tongue in which systemic evaluation was performed on all patients to exclude systemic disease. Additionally, 3 of the cases underwent repeat systemic evaluation 6 months to 2 years after their original diagnosis.</p>
<p>As with many of the previously reported cases of localized tongue amyloidosis, the 6 patients in this case series presented with a rubbery to firm mass on the tongue rather than macroglossia. Similar to other cases of localized tongue amyloidosis,<sup><xref ref-type="bibr" rid="bibr5-0194599813490896">5</xref></sup> 1 of our patients developed recurrence in the localized lesion within 1 year. Recurrences have been reported in other areas of head and neck localized amyloidosis.<sup><xref ref-type="bibr" rid="bibr24-0194599813490896">24</xref></sup> McAlpine and Fuller<sup><xref ref-type="bibr" rid="bibr6-0194599813490896">6</xref></sup> report on a case of localized laryngeal amyloidosis recurring 10 years after the primary resection.</p>
<p>In the cases seen in follow-up, repeat systemic evaluation remained negative. In contrast to the more lethal systemic amyloidosis with tongue involvement, localized tongue amyloidosis appears to have indolent course, similar to that of localized amyloidosis in other regions of the head and neck.<sup><xref ref-type="bibr" rid="bibr2-0194599813490896">2</xref>,<xref ref-type="bibr" rid="bibr15-0194599813490896">15</xref></sup> Michaels and Hyams<sup><xref ref-type="bibr" rid="bibr25-0194599813490896">25</xref></sup> report on 25 cases of localized amyloidosis of the respiratory tract. Twelve of the cases were followed from 5 months to 10 years. Although localized disease recurrence occurred, no patients went on to develop systemic amyloidosis.</p>
<p>Given the rarity of this disease, it is essential to thoroughly rule out systemic involvement in patients with diagnosed amyloidosis involving the tongue. This includes a bone marrow biopsy, abdominal fat aspirate analysis, and urine and serum immunoelectrophoresis. Further cardiac and renal assessment as well as symptom-directed work-up of other organ systems in also prudent. Similar to other areas of localized amyloidosis, patients with localized tongue amyloidosis do not appear to be at increased risk of developing systemic disease.<sup><xref ref-type="bibr" rid="bibr3-0194599813490896">3</xref></sup> Therefore, once systemic involvement is ruled out at the initial evaluation, repeat evaluation may not be necessary.</p>
</sec>
<sec id="section11-0194599813490896" sec-type="conclusions">
<title>Conclusion</title>
<p>Our case series confirms that localized amyloidosis of the tongue remains a rare diagnosis, which makes exclusion of systemic involvement necessary in all patients. Once systemic involvement is ruled out, amyloid lesions may be observed or resected if symptomatic. Although we present a limited number of cases with follow-up, this case series suggests that localized amyloidosis of the tongue has an indolent course and an overall good prognosis with minimal intervention. Future case series with longer follow-up are needed to fully explore the long-term prognosis of localized amyloidosis of the tongue.</p>
</sec>
<sec id="section12-0194599813490896">
<title>Author Contributions</title>
<p><bold>Ashley O’Reilly</bold>, acquisition of data, drafting article, final approval of manuscript; <bold>Anita D’Souza</bold>, acquisition of data, drafting article, final approval of manuscript; <bold>John Lust</bold>, acquisition of data, final approval of manuscript; <bold>Daniel Price</bold>, acquisition of data, final approval of manuscript.</p>
</sec>
<sec id="section13-0194599813490896">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> None.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
<p>This article was presented as a poster at the 2012 AAO-HNSF Annual Meeting &amp; OTO EXPO; September 9-12, 2012; Washington, DC.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599813490896">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sipe</surname><given-names>JD</given-names></name>
<name><surname>Benson</surname><given-names>MD</given-names></name>
<name><surname>Buxbaum</surname><given-names>JN</given-names></name>
<etal/>
</person-group>. <article-title>Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis</article-title>. <source>Amyloid</source>. <year>2010</year>;<volume>17</volume>:<fpage>101</fpage>-<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr2-0194599813490896">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kyle</surname><given-names>RA</given-names></name>
<name><surname>Bayrd</surname><given-names>ED</given-names></name>
</person-group>. <article-title>Amyloidosis: review of 236 cases</article-title>. <source>Medicine</source>. <year>1975</year>;<volume>54</volume>:<fpage>271</fpage>-<lpage>782</lpage>.</citation>
</ref>
<ref id="bibr3-0194599813490896">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fahrner</surname><given-names>KS</given-names></name>
<name><surname>Black</surname><given-names>CC</given-names></name>
<name><surname>Gosselin</surname><given-names>BJ</given-names></name>
</person-group>. <article-title>Localized amyloidosis of the tongue: a review</article-title>. <source>Am J Otolaryngol</source>. <year>2004</year>;<volume>25</volume>:<fpage>186</fpage>-<lpage>189</lpage>.</citation>
</ref>
<ref id="bibr4-0194599813490896">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Penner</surname><given-names>CR</given-names></name>
<name><surname>Muller</surname><given-names>S</given-names></name>
</person-group>. <article-title>Head and neck amyloidosis: a clinicopathologic study of 15 cases</article-title>. <source>Oral Oncol</source>. <year>2006</year>;<volume>42</volume>:<fpage>421</fpage>-<lpage>429</lpage>.</citation>
</ref>
<ref id="bibr5-0194599813490896">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haraguchi</surname><given-names>H</given-names></name>
<name><surname>Ohashi</surname><given-names>K</given-names></name>
<name><surname>Yamada</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Primary localized nodule tongue amyloidosis associated with Sjogren’s Syndrome</article-title>. <source>ORL J Otorhinolaryngol Relat Spec</source>. <year>1997</year>;<volume>59</volume>:<fpage>60</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr6-0194599813490896">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McAlpine</surname><given-names>JC</given-names></name>
<name><surname>Fuller</surname><given-names>AP</given-names></name>
</person-group>. <article-title>Localized laryngeal amyloidosis, a report of a case with a review of the literature</article-title>. <source>J Laryngol Otol</source>. <year>1964</year>;<volume>78</volume>:<fpage>296</fpage>-<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr7-0194599813490896">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Angiero</surname><given-names>F</given-names></name>
<name><surname>Seramondi</surname><given-names>R</given-names></name>
<name><surname>Magistro</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Amyloid deposition in the tongue: clinical and histopathological profile</article-title>. <source>Anticancer Res</source>. <year>2010</year>:<volume>30</volume>:<fpage>3009</fpage>-<lpage>3014</lpage>.</citation>
</ref>
<ref id="bibr8-0194599813490896">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andreadis</surname><given-names>D</given-names></name>
<name><surname>Poulopoulos</surname><given-names>A</given-names></name>
<name><surname>Papadopoulos</surname><given-names>P</given-names></name>
<name><surname>Epivatianos</surname><given-names>A</given-names></name>
</person-group>. <article-title>Localized tongue amyloidosis in a patient with Neurofibromatosis Type II</article-title>. <source>Head Neck Pathol</source>. <year>2011</year>;<volume>5</volume>:<fpage>302</fpage>-<lpage>305</lpage>.</citation>
</ref>
<ref id="bibr9-0194599813490896">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Akyildiz</surname><given-names>A</given-names></name>
<name><surname>Doganavsargil</surname><given-names>B</given-names></name>
<name><surname>Gode</surname><given-names>S</given-names></name>
<name><surname>Veral</surname><given-names>A</given-names></name>
</person-group>. <article-title>Solitary amyloid tumor of the tongue base</article-title>. <source>Int J Otolaryngol</source>. <year>2009</year>;<volume>2009</volume>:<fpage>515068</fpage>-<lpage>515071</lpage>.</citation>
</ref>
<ref id="bibr10-0194599813490896">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koren</surname><given-names>R</given-names></name>
<name><surname>Veltman</surname><given-names>V</given-names></name>
<name><surname>Halpern</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Localized amyloid tumor of the tongue. A case report and review of the literature</article-title>. <source>Rom J Morphol Embryol</source>. <year>1998</year>;<volume>44</volume>:<fpage>179</fpage>-<lpage>182</lpage>.</citation>
</ref>
<ref id="bibr11-0194599813490896">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamoaka</surname><given-names>Y</given-names></name>
<name><surname>Suzuki</surname><given-names>A</given-names></name>
<name><surname>Hatakeyama</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Median rhomboid glossitis associated with amyloid deposition</article-title>. <source>Act Pathol Jpn</source>. <year>1978</year>;<volume>23</volume>:<fpage>319</fpage>-<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr12-0194599813490896">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Waal</surname><given-names>RI</given-names></name>
<name><surname>van de Scheur</surname><given-names>MR</given-names></name>
<name><surname>Huijigens</surname><given-names>PC</given-names></name>
<etal/>
</person-group>. <article-title>Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia</article-title>. <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>. <year>2002</year>;<volume>94</volume>:<fpage>444</fpage>-<lpage>447</lpage>.</citation>
</ref>
<ref id="bibr13-0194599813490896">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gertz</surname><given-names>MA</given-names></name>
<name><surname>Lacy</surname><given-names>MQ</given-names></name>
<name><surname>Dispenzieri</surname><given-names>A</given-names></name>
</person-group>. <article-title>Amyloidosis</article-title>. <source>Hematol Oncol Clin North Am</source>. <year>1999</year>;<volume>13</volume>:<fpage>1211</fpage>-<lpage>1233</lpage>.</citation>
</ref>
<ref id="bibr14-0194599813490896">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Touart</surname><given-names>DM</given-names></name>
<name><surname>Sau</surname><given-names>P</given-names></name>
</person-group>. <article-title>Cutaneous deposition disease. Part I</article-title>. <source>J Am Acad Dermatol</source>. <year>1998</year>;<volume>39</volume>:<fpage>149</fpage>-<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr15-0194599813490896">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kerner</surname><given-names>MM</given-names></name>
<name><surname>Wang</surname><given-names>MB</given-names></name>
<name><surname>Angier</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Amyloidosis of the head and neck—a clinicopathologic study of the UCLA experience, 1955-1991</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>1995</year>;<volume>121</volume>:<fpage>778</fpage>-<lpage>782</lpage>.</citation>
</ref>
<ref id="bibr16-0194599813490896">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pentenero</surname><given-names>M</given-names></name>
<name><surname>Davico Bonino</surname><given-names>L</given-names></name>
<name><surname>Tomasini</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Localized oral amyloidosis of the palate</article-title>. <source>Amyloid</source>. <year>2006</year>;<volume>13</volume>:<fpage>42</fpage>-<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr17-0194599813490896">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Capizzi</surname><given-names>SA</given-names></name>
<name><surname>Betancourt</surname><given-names>E</given-names></name>
<name><surname>Prakash</surname><given-names>UB</given-names></name>
</person-group>. <article-title>Tracheobronchial amyloidosis</article-title>. <source>Mayo Clinic Proc</source>. <year>2000</year>;<volume>75</volume>:<fpage>1148</fpage>-<lpage>1152</lpage>.</citation>
</ref>
<ref id="bibr18-0194599813490896">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tirzaman</surname><given-names>O</given-names></name>
<name><surname>Wahner-Roedler</surname><given-names>DL</given-names></name>
<name><surname>Malek</surname><given-names>RS</given-names></name>
<etal/>
</person-group>. <article-title>Primary localized amyloidosis of the urinary bladder: a cases series of 31 patients</article-title>. <source>Mayo Clin Proc</source>. <year>2000</year>;<volume>75</volume>:<fpage>1264</fpage>-<lpage>1268</lpage>.</citation>
</ref>
<ref id="bibr19-0194599813490896">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Biewend</surname><given-names>ML</given-names></name>
<name><surname>Menke</surname><given-names>DM</given-names></name>
<name><surname>Calamia</surname><given-names>KT</given-names></name>
</person-group>. <article-title>The spectrum of localized amyloidosis: a case series of 20 patients</article-title>. <source>Amyloid</source>. <year>2006</year>;<volume>13</volume>:<fpage>135</fpage>-<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr20-0194599813490896">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Wal</surname><given-names>N</given-names></name>
<name><surname>Henzen-Logmans</surname><given-names>S</given-names></name>
<name><surname>van der Kwast</surname><given-names>WA</given-names></name>
<name><surname>van der Waal</surname><given-names>I</given-names></name>
</person-group>. <article-title>Amyloidosis of the tongue: a clinical and postmortem study</article-title>. <source>J Oral Pathol</source>. <year>1984</year>;<volume>13</volume>:<fpage>632</fpage>-<lpage>639</lpage>.</citation>
</ref>
<ref id="bibr21-0194599813490896">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dendy</surname><given-names>RA</given-names></name>
<name><surname>Davis</surname><given-names>JR</given-names></name>
<name><surname>Gorst</surname><given-names>DW</given-names></name>
</person-group>. <article-title>A tongue resection in macroglossia due to primary amyloidosis</article-title>. <source>Br J Oral Maxillofac Surg</source>. <year>1989</year>;<volume>27</volume>:<fpage>329</fpage>-<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr22-0194599813490896">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guijarro-Martinez</surname><given-names>R</given-names></name>
<name><surname>Miragall Alba</surname><given-names>L</given-names></name>
<name><surname>Villar Puchades</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Rational management of macroglossia due to acquired systemic amyloidosis: does surgery play a role?</article-title> <source>J Oral Maxillofac Surg</source>. <year>2009</year>;<volume>67</volume>:<fpage>2013</fpage>-<lpage>2017</lpage>.</citation>
</ref>
<ref id="bibr23-0194599813490896">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>LD</given-names></name>
<name><surname>Derringer</surname><given-names>GA</given-names></name>
<name><surname>Wenig</surname><given-names>BM</given-names></name>
</person-group>. <article-title>Amyloidosis of the larynx: a clinicopathologic study of 11 cases</article-title>. <source>Modern Pathol</source>. <year>2000</year>;<volume>13</volume>:<fpage>528</fpage>-<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr24-0194599813490896">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simpson</surname><given-names>GT</given-names><suffix>II</suffix></name>
<name><surname>Strong</surname><given-names>MS</given-names></name>
<name><surname>Skinner</surname><given-names>M</given-names></name>
<name><surname>Cohen</surname><given-names>AS</given-names></name>
</person-group>. <article-title>Localized amyloidosis of the head and neck and upper aerodigestive and lower respiratory tracts</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>1984</year>;<volume>93</volume>:<fpage>374</fpage>-<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr25-0194599813490896">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Michaels</surname><given-names>L</given-names></name>
<name><surname>Hyams</surname><given-names>VJ</given-names></name>
</person-group>. <article-title>Amyloid in localized deposits and plasmacytomas of the respiratory tract</article-title>. <source>J Pathol</source>. <year>1979</year>;<volume>128</volume>:<fpage>29</fpage>-<lpage>38</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>